期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY LetPub Score 6.2
50 ratings
Rate
Reputation 7.5 Influence 5.0 Speed 7.0 | ||||||||||||||||
期刊簡稱 | CLIN EXP OPHTHALMOL | ||||||||||||||||
ISSN | 1442-6404 | ||||||||||||||||
E-ISSN | 1442-9071 | ||||||||||||||||
h-index | 67 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 10.20%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1442-9071/issues | ||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/ceo | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Wiley-Blackwell Publishing Ltd | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | AUSTRALIA | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 2000 | ||||||||||||||||
每年文章數 | 68每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 27.45% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1442-6404%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY] 的評論 | 撰寫評論 |
作者: 仲夏美媛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-06 19:03:42 評論於 The overall process of CEO Magazine is quite fast. The original article was submitted on 23-10-05, the external review came back on 23-12-03, disagreeing with publication in article format but suggesting publication in letter format. The letter was submitted on 23-12-04, delayed by about 2 weeks due to Christmas, feedback was received on 24-1-26, revisions were made on 24-02-03, and accepted on 23-02-05. The efficiency of the editorial department is still quite high and worth submitting again(0) 讚! | 仲夏美媛 |
作者: 一条小天禄 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-25 11:14:28 評論於 So is it?(0) 讚! | 一条小天禄 |
作者: 玉霄舒荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-19 16:11:20 評論於 Is this magazine displayed as "under review" immediately upon submission?(0) 讚! | 玉霄舒荣 |
作者: 玉霄舒荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-19 10:52:30 評論於 Is this magazine immediately displayed as "under review" upon submission?(0) 讚! | 玉霄舒荣 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:38:49 評論於 Revise, that is, modify the response. In the submission and publication of articles in SCI journals, it is necessary to make appropriate modifications in response to editor's letters, and to provide a detailed explanation of the modifications in the reply to the editor, as a step to apply for re-examination of the manuscript(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:39:09 評論於 Revised Response: We need to provide a detailed response to the revisions suggested by the reviewer(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:08:27 評論於 What does "俢回" mean?(0) 讚! | 魂魄彦露 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:43:11 評論於 What does reciprocity include?(0) 讚! | 陶宜三岁啦 |
作者: 留云英资 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-08 17:09:23 評論於 $2750(0) 讚! | 留云英资 |
作者: 白莲可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-10 10:19:25 評論於 May I ask how much the layout fee is? lixinyuexinyue 2020-01-14 10:36:00 Submitted on December 30, 2019, rejected on January 13, 2020, without specifying any issues(0) 讚! | 白莲可爱吗 |
作者: 一吃就胖小岚翠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-28 23:48:48 評論於 What direction is the article that was submitted?(0) 讚! | 一吃就胖小岚翠 |
作者: 锐志超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-14 17:53:05 評論於 Review Speed: 1.0 Experience Sharing: Submitted on December 30, 2019, rejected on January 13, 2020, with no feedback provided(0) 讚! | 锐志超级甜 |
作者: 绵掌锦欣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-12-03 15:50:52 評論於 Submitted a forward-looking observation, got rejected straight in 2 weeks...probably not enough examples(0) 讚! | 绵掌锦欣 |
作者: 北国天路 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-01 16:10:51 評論於 Review speed: 2.0 | Submission success rate: 25.0 Experience sharing: It is very difficult to publish now *** is a prospective study. I submitted a retrospective study before. The reviewer's comments were okay. However, it was still rejected after revisions(0) 讚! | 北国天路 |
作者: 太山和雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-09-11 17:41:55 評論於 Review speed: 2.0 | Submission success rate: 75.0 Experience sharing: There is a schedule for the publication of each article on the official website, and the overall process is relatively fast. It only takes 5 months to reach online publication, which is quite suitable for novice submissions(0) 讚! | 太山和雅 |
作者: Tom Alfred 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-06-04 19:42:39 評論於 Revised once after a tragedy, raised some new questions, but did not give a chance for a second revision(0) 讚! | Tom Alfred |
作者: Tom Alfred 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-05-10 23:21:46 評論於 It has been 2 months since the manuscript submission, feeling anxious(0) 讚! | Tom Alfred |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-04-15 17:56:18 評論於 The review comments will be provided soon(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-02-27 14:39:17 評論於 Review speed: 2.0 | Submission acceptance rate: 75.0 Experience sharing: I received a reply in less than 2 months after submitting, and the paper was accepted after minor revisions, suitable for domestic authors to publish(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us